Shree Ganesh Bio-Tech (India) Limited

BSE:539470 Stock Report

Market Cap: ₹414.6m

Shree Ganesh Bio-Tech (India) Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Aman Patel

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.5yrs
CEO ownershipn/a
Management average tenure3yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

CEO

Aman Patel (26 yo)

4.5yrs

Tenure

Mr. Aman Patel serves as a Whole-time Director at Shree Ganesh Bio-Tech (India) Limited since March 21, 2020 and its Chairman and Compliance Officer. He is an Independent Director of LUCENT INDUSTRIES LIMI...

Leadership Team

NamePositionTenureCompensationOwnership
Aman Patel
Chairman & Compliance Officer4.5yrsno datano data
Kishan Naidu
CFO & Non-Executive Director2.4yrsno datano data
Namita Acharya
Company Secretary3yrsno datano data

3.0yrs

Average Tenure

Experienced Management: 539470's management team is considered experienced (3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Aman Patel
Chairman & Compliance Officer4.8yrsno datano data
Kishan Naidu
CFO & Non-Executive Director4.5yrsno datano data
Sombir Singh
Non-Executive Independent Director7yrsno datano data
Nimeshkumar Parmar
Independent Director2.4yrsno datano data
Amrutaben Solanki
Independent Director2.4yrsno datano data
Harshad Rathod
Independent Director1.8yrsno datano data

3.5yrs

Average Tenure

35.5yo

Average Age

Experienced Board: 539470's board of directors are considered experienced (3.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 05:44
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shree Ganesh Bio-Tech (India) Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution